VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancer

Journal of Surgical Oncology

Volumn 102, Issue 4, 2010, Pages 325-330

  Wang, Xin ^a,b   Cao, Weiguo ^c   Mo, Mingcong ^d   Wang, Wei ^d   Wu, Huita ^b   Wang, Jiejun ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cortactin; Gastric cancer; Prognostic factor; Tumor recurrence; Vascular endothelial growth factor

Indexed keywords

CAPECITABINE; CISPLATIN; CORTACTIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; VASCULOTROPIN;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; TUMOR DIFFERENTIATION;

ADULT; AGED; CORTACTIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77956580659     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21644     Document Type: Article

References (28)

1. Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
2. Averbach AM, Jacquet P: Strategies to decrease the incidence of intra-abdominal recurrence in resectable gastric cancer. Br J Surg 1996;83:726-733.
3. Saito H, Osaki T, Murakami D, et al.: Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters. J Surg Oncol 2007;95:123-128. (Pubitemid 46238980)
4. Kolev Y, Uetake H, Takagi Y, et al.: Lactate dehydrogenase-5 (LDH-5) expression in human gastric cancer: Association with hypoxia-inducible factor (HIF-1alpha) pathway, angiogenic factors production and poor prognosis. Ann Surg Oncol 2008;15:2336-2344.
5. Maeda K, Chung YS, Ogawa Y, et al.: Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996;77:858-863. (Pubitemid 26061277)
6. Leung DW, Cachianes G, Kuang WJ, et al.: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1306-1309. (Pubitemid 20066716)
7. Poon RT, Fan ST, Wong J: Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol 2001;19:1207-1225.
8. Fondevila C, Metges JP, Fuster J, et al.: p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. Br J Cancer 2004;90:206-215. (Pubitemid 38174963)
9. Baba M, Konno H, Maruo Y, et al.: Relationship of p53 and vascular endothelial growth factor expression of clinicopathological factors in human scirrhous gastric cancer. Eur Surg Res 1998;30:130-137.
10. Tanigawa N, Amaya H, Matsumura M, et al.: Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. J Clin Oncol 1997;15:826-832. (Pubitemid 27074254)
11. Yao JC, Wang L, Wei D, et al.: Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin Cancer Res 2004;10:4109-4117. (Pubitemid 38812490)
12. van Rossum AG, Moolenaar WH, Schuuring E: Cortactin affects cell migration by regulating intercellular adhesion and cell spreading. Exp Cell Res 2006;312:1658-1670.
13. Weaver AM, Karginov AV, Kinley AW, et al.: Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation. Curr Biol 2001;11:370-374.
14. Schuuring E: The involvement of the chromosome 11q13 region in human malignancies: Cyclin D1 and EMS1 are two new candidate oncogenes - A review. Gene 1995;159:83-96.
15. Ormandy CJ, Musgrove EA, Hui R, et al.: Cyclin D1, EMS1 and 11q13 amplification in breast cancer. Breast Cancer Res Treat 2003;78:323-335.
16. Lee YY, Yu CP, Lin CK, et al.: Expression of survivin and cortactin in colorectal adenocarcinoma: Association with clinicopathological parameters. Dis Markers 2009;26:9-18.
17. Schuuring E, Verhoeven E, van Tinteren H, et al.: Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res 1992;52:5229-5234.
18. Tsai WC, Jin JS, Chang WK, et al.: Association of cortactin and fascin-1 expression in gastric adenocarcinoma: Correlation with clinicopathological parameters. J Histochem Cytochem 2007;55:955-962. (Pubitemid 47293841)
19. Sobin LH, Fleming ID: TNM Classification of Malignant tumours, fifth edition (1997) Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997;80:1803-1804.
20. Hemilton SR, Aaltonen LA: Tumors of the digestive system in WHO classification of tumors. Lyon: IRAC Press; 2000.
21. Zhu CQ, Shih W, Ling CH, et al.: Immunohistochemical markers of prognosis in non-small cell lung cancer: A review and proposal for a multiphase approach to marker evaluation. J Clin Pathol 2006;59:790-800. (Pubitemid 44211740)
22. Au NH, Cheang M, Huntsman DG, et al.: Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: A tissue microarray study of 284 cases and 18 markers. J Pathol 2004;204:101-109.
23. Tanigawa N, Amaya H, Matsumura M, et al.: Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res 1996;56:2671-2676. (Pubitemid 26170706)
24. Kitadai Y, Haruma K, Tokutomi T, et al.: Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas. Clin Cancer Res 1998;4:2195-2200. (Pubitemid 28415667)
25. Gasparini G, Toi M, Gion M, et al.: Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J Natl Cancer Inst 1997;89:139-147.
26. Fontanini G, Vignati S, Boldrini L, et al.: Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res 1997;3:861-865. (Pubitemid 27252933)
27. Paley PJ, Staskus KA, Gebhard K, et al.: Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer 1997;80:98-106. (Pubitemid 27270925)
28. Weaver AM: Cortactin in tumor invasiveness. Cancer Lett 2008;265:157-166.